US Food and Drug Administration Approval of Flibanserin: Even the Score Does Not Add Up

JAMA Intern Med. 2016 Apr;176(4):439-42. doi: 10.1001/jamainternmed.2016.0073.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Benzimidazoles / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Drug Approval*
  • Evidence-Based Medicine
  • Female
  • Humans
  • Patient Satisfaction
  • Sexual Dysfunctions, Psychological / drug therapy*
  • United States
  • United States Food and Drug Administration

Substances

  • Benzimidazoles
  • flibanserin